Home
/
Sotera Health Co
/
Financials
/
Quarterly
Sotera Health Co — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Sotera Health Co filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$311.31M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$294.34M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$254.52M
May 1, 2025
Q3
2025
Sep 30, 2024
$285.47M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$276.59M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$248.18M
May 1, 2025
Q3
2024
Sep 30, 2023
$263.18M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$255.28M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$220.59M
May 2, 2024
Q3
2023
Sep 30, 2022
$248.70M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$266.64M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$236.75M
May 3, 2023
Q3
2022
Sep 30, 2021
$226.16M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$251.92M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$212.15M
May 5, 2022
Q3
2021
Sep 30, 2020
$200.03M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$213.09M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$188.20M
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$48.40M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$7.96M
Aug 8, 2025
Q3
2025
Sep 30, 2024
$17.00M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$8.75M
Aug 8, 2025
Q3
2024
Sep 30, 2023
($13.66M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
$23.51M
Aug 5, 2024
Q3
2023
Sep 30, 2022
$25.09M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$30.42M
Aug 3, 2023
Q1
2022
Mar 31, 2022
$30.64M
May 5, 2022
Q3
2022
Sep 30, 2021
$27.44M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$42.60M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$10.84M
May 5, 2022
Q3
2021
Sep 30, 2020
$10.0K
Nov 10, 2021
Q2
2021
Jun 30, 2020
$7.02M
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.96M)
May 13, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$80.51M
Nov 5, 2024
Q2
2024
Jun 30, 2024
$76.80M
Aug 5, 2024
Q1
2024
Mar 31, 2024
$53.17M
May 2, 2024
Q3
2024
Sep 30, 2023
$76.10M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$63.20M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$33.37M
May 2, 2024
Q3
2023
Sep 30, 2022
$63.20M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$71.50M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$53.49M
May 3, 2023
Q3
2022
Sep 30, 2021
$65.67M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$78.27M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$46.36M
May 5, 2022
Q3
2021
Sep 30, 2020
$47.03M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$61.74M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$44.87M
May 13, 2021